Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Neuropharmacology ; 92: 56-62, 2015 May.
Article in English | MEDLINE | ID: mdl-25576370

ABSTRACT

Here, we define a protophenotype as an endophenotype that has been conserved during evolution. Social feeding in Caenorhabditis elegans may be an example of a protophenotype related to asociality in schizophrenia. It is regulated by the highly conserved neuropeptide Y receptor, NPR-1, and we speculated that social feeding should be affected by antipsychotic drugs. The social feeding strain, npr-1(g320), was exposed to antipsychotic drugs, dopamine or calmodulin antagonists on plates with bacterial lawns, and the number of aggregates on the plates was counted as a measure of social feeding. First-generation antipsychotics, chlorpromazine, trifluoperazine, fluphenazine, and haloperidol, and the second-generation drug, olanzapine, inhibited social feeding. Dopamine accelerated aggregation, whereas selective D2 dopamine receptor antagonists, sulpiride and raclopride, were inhibitory. Calmodulin antagonists effectively inhibited social feeding, as did RNAi knockdown of calmodulin (cmd-1) expression. In addition, gap junction inhibitors prevented aggregation, which is consistent with the hub-and-spoke arrangement of neurons that regulate social feeding via functional gap junctions. The studies described here revealed novel connections between dopaminergic signaling, the NPY receptor, calmodulin, and gap junctions in the regulation of social behavior in C. elegans. These pathways are evolutionarily-conserved, and have also been implicated in the pathogenesis of schizophrenia.


Subject(s)
Antipsychotic Agents/pharmacology , Caenorhabditis elegans Proteins/metabolism , Calmodulin/pharmacology , Feeding Behavior/drug effects , Receptors, Neuropeptide Y/metabolism , Social Behavior , Animals , Animals, Genetically Modified , Caenorhabditis elegans , Caenorhabditis elegans Proteins/genetics , Calmodulin/antagonists & inhibitors , Dopamine/pharmacology , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Gap Junctions/drug effects , Gap Junctions/genetics , Imidazoles/pharmacology , Phenotype , RNA, Small Interfering/pharmacology , Receptors, Neuropeptide Y/genetics , Sulfonamides/pharmacology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...